
Pilbara Minerals tops most-viewed after FY27 outlook; 4DMedical shares climb on 23% revenue lift; Dateline Resources extends trading suspension. Liontown and BrainChip also draw investor debate.
HotCopper's most-viewed and most-discussed lists for Week 31 were dominated by mining and tech names, with Pilbara Minerals, Dateline Resources and Strike Energy drawing the heaviest traffic, while 4DMedical, Liontown Resources and BrainChip generated the most investor debate.
Pilbara Minerals topped the most-viewed list after delivering its June quarter update and FY27 outlook. The lithium producer exceeded FY26 production guidance and forecast higher output in the year ahead. Investors are weighing whether operational improvements can offset the continued weakness in lithium prices.
Dateline Resources attracted strong interest after requesting and extending a voluntary trading suspension on the ASX. The move is tied to an ongoing U.S. District Court motion related to a preliminary injunction for the Colosseum Gold Project, the company said. The suspension remains in place as the court process unfolds.
Strike Energy rounded out the most-viewed trio after reporting quarterly operational and production updates. The company posted over $13 million in revenue and reached mechanical completion at its South Erregulla Peaking Power Station. The market remains focused on cash generation, Perth Basin developments and progress across its gas portfolio.
Over in the most discussed stocks, 4DMedical continued generating conversation after releasing its quarterly update. The update highlighted commercial progress, new contract momentum and further rollout of its respiratory imaging platform across key healthcare markets. 4DMedical shares climbed this week following a 23% full-year operating revenue lift to $7.2 million, driven by a surge in scan volumes.
Liontown Resources remained firmly in focus after its quarterly results. Investors debated production performance at Kathleen Valley, ramp-up progress and what improving operational execution could mean for Australia's newest major lithium producer.
BrainChip completed the list as investors continued discussing the commercial rollout of its Akida neuromorphic AI technology. Attention remains on customer adoption, production availability of the AKD1500 processor and commercialisation opportunities in edge AI applications.
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions.
Prepared with AlphaScala editorial tooling from the source reporting linked above. Indexable analysis may include a cited Alpha Score value. Publishing checks screen each story before release. Educational coverage, not personalized advice.